Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07501533

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07501533
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07501533. Randomized; no masking; primary purpose treatment. Start 2026-06-18 (actual); primary completion 2028-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
Condition
Severe Stroke
Intervention (Drug)
Intravenous insulin
Lead sponsor
First Affiliated Hospital of Wannan Medical College (class: other)

Record details

Record id
cardio:ct-nct07501533
Content hash
8d9806610373f40aac9696c94f7e2dd82de5fc0901e3fd259b82a226c9bec24c